.1mjauleg92t94.webp&w=3840&q=75){kind=logo}
On 3 February 2026, Dr. Christeen Youssef led the signing of a landmark scientific collaboration agreement between Everlast Wellness Medical Center and the German University. The partnership establishes a framework for the exchange of scientific knowledge, expertise and best practice in the field of stem cell research and its modern applications in regenerative medicine.
Research, Training and Therapeutic Protocols
The agreement focuses on collaborative research initiatives, joint training programmes, and the development of innovative therapeutic protocols that carry cutting-edge stem cell technologies into clinical practice. Dr. Christeen highlighted the importance of bridging academic research with practical medical application — so that discoveries in stem cell biology are translated into treatments that are safe and effective for the patient in front of you.
The collaboration also opens the way for faculty and student exchanges, joint workshops and shared publications, so that what is learned moves between international scientific communities rather than staying inside one of them.
A Regional Hub for Regenerative Medicine
Through this partnership Everlast reinforces its commitment to scientific excellence and innovation, positioning itself as a regional hub for advanced regenerative medicine research. Dr. Christeen emphasised that the collaboration will not only extend the centre’s research capability but also open access to state-of-the-art methodologies, contributing to the development of novel therapies across a range of medical conditions.
What the Agreement Represents
By combining the strengths of Everlast and the German University, the agreement marks a significant step forward in advancing global stem cell research, improving clinical outcomes, and sustaining international collaboration in a field that is moving quickly. It sets the terms under which the two institutions will work as one research community rather than two that occasionally correspond.
